Objective To evaluate the efficacy and safety of gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
目的 观察吉非替尼单药治疗对晚期非小细胞肺癌 （NSCLC） 老年患者的效果和安全性。
Conclusion For elderly patients with advanced non-small cell lung cancer and COPD, the use of erlotinib might achieve better security and effectiveness.
结论厄洛替尼单药对晚期非小细胞肺癌合并COPD的患者不良反应小，耐受性好，疗效可接受。
To evaluate the clinical efficacy and the security of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer and COPD.
评价单药厄洛替尼治疗晚期非小细胞肺癌合并COPD患者的疗效和安全性。
应用推荐